Patent 11767514 was granted and assigned to Prellis Biologics, Inc on September, 2023 by the United States Patent and Trademark Office.
Provided herein are methods and systems for bio-printing of three-dimensional organs and organoids. Also provided herein are bio-printed three-dimensional organs and organoids for use in the generation and/or the assessment of immunological products and/or immune responses. Also provided herein are methods and system for bio-printing three-dimensional matrices.